RE: C'mon Myles more pumping less dumping9 Jul 2021 01:16
Hi MayAnya.
Are you referring to the update on 20th May ?
If so, I can't see any reference to 8 weeks (bu it is late, and I'm not at 100% attention tonight).
Nigel does say: "Whilst the results from the work at Evotec may be a little later than expected, we remain more optimistic as to the outcome following the results seen in the pilot study and I look forward to providing further updates as soon as practicable in the coming months."
Completely agree with your "hold hold hold" sentiment, though. Only an idiot would sell now.
This is what I infer from that same statement in May:
Nuvec monodisperse formulation / in-vivo -. . . . the pilot study "will be repeated and extended to validate the results seen from this pilot study which, if consistent, would demonstrate a significant improvement through the use of this newly formulated Nuvec®. " So, I think we can expect an update on that in coming months. When ? Maybe next week. Maybe September. Who knows - Nigel didn't offer a scheduled roadmap.
Evotec . . . . the RNS states: "it is likely to push any results from the Evotec in vivo work into the third quarter of this year". Well, we're 1 week into Q3, with 12 weeks to go. So, results could be published any day, but I'd imagine it's more likely to be in a few weeks, rather than a few days. Of course, I may be totally wrong and an RNS pops up tomorrow morning. But better to have bought in now, rather than in 4 or 5 weeks, after the SP has climbed in anticipation. :)
And a word of warning comes from Nigel: "Whilst there can be no guarantee of either agreement resulting in a commercial collaboration, it marks a major step forward as we apply third party materials to Nuvec®".
So do, everyone, bear in mind that both MTAs could conclude without progressing onto a commercial partnership. That's the risk of AIM, and why we put our money in here for a major multi-bag instead of a FTSE350.
Of course we all hope that big step forward DOES happen.
And if a couple more MTAs can be added, then it would add a lot more confidence that at least ONE of them will progress.
Sorry, I'm probably a boring, rational, balanced voice here. To be clear, I do believe N4P has a very good shot at being a significant multi-bagger in the next 12-24 months. But setting expectations more calmly. (cue 7am RNS windfall).
Good luck all.